Antibody Breakthrough Targets Epstein-Barr Virus, Hinting at Transplant Protection
TL;DR Summary
Researchers developed human antibodies against EBV surface proteins gp350 and gp42; in mice with humanized immune systems, one antibody protected against EBV infection, suggesting a new approach to prevent EBV-related diseases and transplant-related cancers, with safety testing and clinical trials planned.
Topics:health#antibodies#epstein-barr-virus#gp350#gp42#post-transplant-lymphoproliferative-disorder#science
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
6 min
vs 6 min read
Condensed
96%
1,144 → 41 words
Want the full story? Read the original article
Read on ScienceAlert